269 related articles for article (PubMed ID: 8387249)
21. Experimental infection of fattening pigs with pseudorabies (Aujeszky's disease) virus: efficacy of attenuated live- and inactivated-virus vaccines in pigs with or without passive immunity.
Vannier P
Am J Vet Res; 1985 Jul; 46(7):1498-502. PubMed ID: 2992327
[TBL] [Abstract][Full Text] [Related]
22. Genetic immunization of seronegative one-day-old piglets against pseudorabies induces neutralizing antibodies but not protection and is ineffective in piglets from immune dams.
Monteil M; Le Potier MF; Guillotin J; Cariolet R; Houdayer C; Eloit M
Vet Res; 1996; 27(4-5):443-52. PubMed ID: 8822614
[TBL] [Abstract][Full Text] [Related]
23. A vaccine strain of pseudorabies virus with deletions in the thymidine kinase and glycoprotein X genes.
Marchioli CC; Yancey RJ; Wardley RC; Thomsen DR; Post LE
Am J Vet Res; 1987 Nov; 48(11):1577-83. PubMed ID: 2829665
[TBL] [Abstract][Full Text] [Related]
24. Latent infection and subsequent reactivation of pseudorabies virus in swine exposed to pseudorabies virus while nursing immune dams.
Mengeling WL
Am J Vet Res; 1989 Oct; 50(10):1658-66. PubMed ID: 2552871
[TBL] [Abstract][Full Text] [Related]
25. Immunogenicity and protective efficacy of recombinant pseudorabies virus expressing the two major membrane-associated proteins of porcine reproductive and respiratory syndrome virus.
Jiang Y; Fang L; Xiao S; Zhang H; Pan Y; Luo R; Li B; Chen H
Vaccine; 2007 Jan; 25(3):547-60. PubMed ID: 16920232
[TBL] [Abstract][Full Text] [Related]
26. Oronasal challenge of fattening pigs after vaccination with an inactivated Aujeszky's disease vaccine.
Pensaert MB; Vandeputte J; Andries K
Res Vet Sci; 1982 Jan; 32(1):12-6. PubMed ID: 6283610
[TBL] [Abstract][Full Text] [Related]
27. Lactogenic immunity and milk antibody isotypes to transmissible gastroenteritis virus in sows exposed to porcine respiratory coronavirus during pregnancy.
Lanza I; Shoup DI; Saif LJ
Am J Vet Res; 1995 Jun; 56(6):739-48. PubMed ID: 7653882
[TBL] [Abstract][Full Text] [Related]
28. Antibody response of pigs to inactivated monovalent and bivalent vaccines for porcine parvovirus and pseudorabies virus.
Mengeling WL; Gutekunst DE; Pirtle EC
Am J Vet Res; 1980 Oct; 41(10):1569-71. PubMed ID: 6261613
[TBL] [Abstract][Full Text] [Related]
29. Immune response of sows and their offspring to pseudorabies virus: serum neutralization response to vaccination and field virus challenge.
Wright JC; Thawley DG; Solorzano RF
Can J Comp Med; 1984 Apr; 48(2):184-91. PubMed ID: 6326982
[TBL] [Abstract][Full Text] [Related]
30. Effect of maternally acquired Aujeszky's disease (pseudorabies) virus-specific antibody in pigs on establishment of latency and seroconversion to differential glycoproteins after low dose challenge.
McCaw MB; Osorio FA; Wheeler J; Xu J; Erickson GA
Vet Microbiol; 1997 Apr; 55(1-4):91-8. PubMed ID: 9220600
[TBL] [Abstract][Full Text] [Related]
31. Attenuated properties of thymidine kinase-negative deletion mutant of pseudorabies virus.
Kit S; Kit M; Pirtle EC
Am J Vet Res; 1985 Jun; 46(6):1359-67. PubMed ID: 2992322
[TBL] [Abstract][Full Text] [Related]
32. Field trial to evaluate the immunogenicity of pseudorabies virus vaccines with deletions for glycoproteins G and E.
Firkins LD; Weigel RM; Biehl LG; Hahn EC
Am J Vet Res; 1997 Sep; 58(9):976-84. PubMed ID: 9285001
[TBL] [Abstract][Full Text] [Related]
33. Second-generation pseudorabies virus vaccine with deletions in thymidine kinase and glycoprotein genes.
Kit S; Sheppard M; Ichimura H; Kit M
Am J Vet Res; 1987 May; 48(5):780-93. PubMed ID: 3035972
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a recombinant vaccinia virus containing pseudorabies (PR) virus glycoprotein genes gp50, gII, and gIII as a PR vaccine for pigs.
Mengeling WL; Brockmeier SL; Lager KM
Arch Virol; 1994; 134(3-4):259-69. PubMed ID: 8129615
[TBL] [Abstract][Full Text] [Related]
35. Immune response of sows vaccinated with attenuated transmissible gastroenteritis virus (TGEV) and recombinant TGEV spike protein vaccines and protection of their suckling pigs against virulent TGEV challenge exposure.
Park S; Sestak K; Hodgins DC; Shoup DI; Ward LA; Jackwood DJ; Saif LJ
Am J Vet Res; 1998 Aug; 59(8):1002-8. PubMed ID: 9706204
[TBL] [Abstract][Full Text] [Related]
36. Protective immunity induced by systemic and mucosal delivery of DNA vaccine expressing glycoprotein B of pseudorabies virus.
Yoon HA; Han YW; Aleyas AG; George JA; Kim SJ; Kim HK; Song HJ; Cho JG; Eo SK
J Microbiol Biotechnol; 2008 Mar; 18(3):591-9. PubMed ID: 18388482
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the safety and efficacy of a thymidine kinase, inverted repeat, gI, and gpX gene-deleted pseudorabies vaccine.
Swenson SL; McMillen J; Hill HT
J Vet Diagn Invest; 1993 Jul; 5(3):341-6. PubMed ID: 8396983
[TBL] [Abstract][Full Text] [Related]
38. Assessment of the effectiveness of vaccination against pseudorabies in finishing pigs.
Stegeman A; Van Nes A; de Jong MC; Bolder FW
Am J Vet Res; 1995 May; 56(5):573-8. PubMed ID: 7661450
[TBL] [Abstract][Full Text] [Related]
39. Vaccine genotype and route of administration affect pseudorabies field virus latency load after challenge.
Vilnis A; Sussman MD; Thacker BJ; Senn M; Maes RK
Vet Microbiol; 1998 May; 62(2):81-96. PubMed ID: 9695282
[TBL] [Abstract][Full Text] [Related]
40. Role of memory B-cell responses in serum and mucosal fluids of swine for protective immunity against pseudorabies virus.
Kimman TG; Oei-Lie N; van Zaane D
Am J Vet Res; 1992 Nov; 53(11):1992-8. PubMed ID: 1334639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
